tiprankstipranks
Utah Medical Products (DE:UTM)
FRANKFURT:UTM
Germany Market
UTM
Utah Medical Products
RESEARCH TOOLSreports

Utah Medical Products (UTM) Ratios

0 Followers

Utah Medical Products Ratios

DE:UTM's free cash flow for Q2 2026 was $0.56. For the 2026 fiscal year, DE:UTM's free cash flow was decreased by $ and operating cash flow was $0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 48.62 37.62 25.64 22.56 15.09
Quick Ratio
 44.27 34.57 23.29 20.53 13.61
Cash Ratio
 0.00 33.01 22.09 19.72 12.59
Solvency Ratio
 5.08 4.35 3.26 3.22 2.45
Operating Cash Flow Ratio
 5.72 5.66 3.95 4.73 3.55
Short-Term Operating Cash Flow Coverage
 0.00 0.00 264.84 0.00 0.00
Net Current Asset Value
$ 98.10M$ 94.47M$ 91.22M$ 99.12M$ 80.30M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.02 1.03 1.04 1.06 1.08
Debt Service Coverage Ratio
 0.00 0.00 297.23 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 <0.01 0.00 0.00
Interest Debt Per Share
 0.06 0.07 0.10 0.08 0.09
Net Debt to EBITDA
 0.01 -5.01 -4.22 -3.74 -2.78
Profitability Margins
Gross Profit Margin
54.88%51.60%59.03%59.81%61.58%
EBIT Margin
33.94%36.63%41.08%36.71%37.85%
EBITDA Margin
40.62%44.29%47.85%49.28%51.40%
Operating Profit Margin
28.46%29.60%33.23%33.40%37.85%
Pretax Profit Margin
35.68%36.63%41.08%40.00%39.52%
Net Profit Margin
29.04%29.30%33.92%33.12%31.51%
Continuous Operations Profit Margin
29.04%29.30%33.92%33.12%31.51%
Net Income Per EBT
81.39%79.99%82.57%82.81%79.74%
EBT Per EBIT
125.38%123.75%123.60%119.74%104.39%
Return on Assets (ROA)
8.42%9.21%11.32%12.28%13.30%
Return on Equity (ROE)
8.74%9.46%11.81%12.96%14.42%
Return on Capital Employed (ROCE)
8.39%9.51%11.44%12.83%16.78%
Return on Invested Capital (ROIC)
6.83%7.60%9.45%10.63%13.38%
Return on Tangible Assets
9.51%10.48%13.08%14.24%16.45%
Earnings Yield
4.63%6.22%6.44%5.43%4.51%
Efficiency Ratios
Receivables Turnover
 10.13 10.94 9.99 14.82 9.44
Payables Turnover
 18.60 20.47 30.87 26.25 16.49
Inventory Turnover
 1.81 2.35 1.90 2.11 2.28
Fixed Asset Turnover
 3.75 3.89 4.19 4.76 5.11
Asset Turnover
 0.29 0.31 0.33 0.37 0.42
Working Capital Turnover Ratio
 0.37 0.41 0.42 0.54 0.68
Cash Conversion Cycle
 218.11 170.88 216.62 183.99 176.70
Days of Sales Outstanding
 36.04 33.37 36.53 24.64 38.66
Days of Inventory Outstanding
 201.70 155.34 191.91 173.26 160.17
Days of Payables Outstanding
 19.63 17.83 11.83 13.90 22.13
Operating Cycle
 237.74 188.71 228.44 197.90 198.84
Cash Flow Ratios
Operating Cash Flow Per Share
 3.72 4.53 4.23 6.13 5.81
Free Cash Flow Per Share
 3.60 4.42 4.17 5.95 5.59
CapEx Per Share
 0.13 0.11 0.07 0.18 0.22
Free Cash Flow to Operating Cash Flow
 0.97 0.97 0.98 0.97 0.96
Dividend Paid and CapEx Coverage Ratio
 2.73 3.37 3.30 4.53 5.31
Capital Expenditure Coverage Ratio
 29.62 39.60 63.11 34.87 25.85
Operating Cash Flow Coverage Ratio
 60.75 65.30 43.88 75.53 62.01
Operating Cash Flow to Sales Ratio
 0.33 0.38 0.36 0.44 0.40
Free Cash Flow Yield
5.06%7.90%6.78%7.07%5.56%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 21.68 16.08 15.52 18.41 22.20
Price-to-Sales (P/S) Ratio
 6.27 4.71 5.26 6.10 6.99
Price-to-Book (P/B) Ratio
 1.85 1.52 1.83 2.39 3.20
Price-to-Free Cash Flow (P/FCF) Ratio
 19.78 12.66 14.75 14.15 17.99
Price-to-Operating Cash Flow Ratio
 19.11 12.34 14.52 13.75 17.29
Price-to-Earnings Growth (PEG) Ratio
 -1.76 -1.33 -1.16 20.85 1.87
Price-to-Fair Value
 1.85 1.52 1.83 2.39 3.20
Enterprise Value Multiple
 15.45 5.61 6.78 8.63 10.83
Enterprise Value
 226.58M 95.78M 132.69M 213.72M 290.92M
EV to EBITDA
 15.45 5.61 6.78 8.63 10.83
EV to Sales
 6.28 2.49 3.24 4.26 5.56
EV to Free Cash Flow
 19.79 6.69 9.09 9.88 14.31
EV to Operating Cash Flow
 19.13 6.52 8.95 9.59 13.76
Tangible Book Value Per Share
 33.84 32.21 28.83 30.16 24.89
Shareholders’ Equity Per Share
 38.33 36.81 33.52 35.28 31.41
Tax and Other Ratios
Effective Tax Rate
 0.19 0.20 0.17 0.17 0.20
Revenue Per Share
 11.34 11.89 11.68 13.81 14.37
Net Income Per Share
 3.29 3.48 3.96 4.57 4.53
Tax Burden
 0.81 0.80 0.83 0.83 0.80
Interest Burden
 1.05 1.00 1.00 1.09 1.04
Research & Development to Revenue
 0.02 0.02 0.02 0.01 <0.01
SG&A to Revenue
 0.25 0.20 0.14 0.22 0.20
Stock-Based Compensation to Revenue
 0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.13 1.30 1.07 1.34 1.28
Currency in USD